Rare statin hepatotoxicity: Convincing evidence based on breakthrough case study

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 699-700

  Teschke, Rolf ^a   Frenzel, Christian ^b   Wolff, Albrecht ^c   Eickhoff, Axel ^d  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d Klinikum Hanau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

DRUG USE; HUMAN; LETTER; LIVER TOXICITY; PRIORITY JOURNAL; TREATMENT DURATION;

DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE;

EID: 84865140816     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.02.031     Document Type: Letter

References (10)

1. E. Björnsson, E.I. Jacobsen, and E. Kalaitzakis Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing J Hepatol 56 2012 374 380
2. T. Bader The myth of statin-induced hepatotoxicity Am J Gastroenterol 105 2010 978 980
3. R. Teschke, A. Schwarzenboeck, and K.H. Hennermann Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases Eur J Gastroenterol Hepatol 20 2008 1182 1193
4. R. Teschke, X. Glass, J. Schulze, and A. Eickhoff Suspected Greater Celandine hepatotoxicity: liver specific causality evaluation of published case reports from Europe Eur J Gastroenterol Hepatol 24 2012 270 280
5. H.J. Zimmerman Hepatotoxicity 1999 Lippincott Williams & Wilkins Philadelphia
6. R. Teschke, A. Schwarzenboeck, and K.H. Hennermann Causality assessment in hepatotoxicity by drugs and dietary supplements Br J Clin Pharmacol 66 2008 758 766
7. M. García-Cortés, C. Stephens, M.I. Lucena, A. Fernández-Castañer, and R.J. Andrade On behalf of the Spanish Group for the Study of Drug-Induced Liver Disease. Causality assessment methods in drug induced liver injury: strengths and weaknesses J Hepatol 55 2011 683 691
8. D. Larrey, and S. Faure Herbal medicine hepatotoxicity: a new step with development of specific biomarkers J Hepatol 54 2011 599 601
9. R. Teschke, A. Schwarzenboeck, W. Schmidt-Taenzer, A. Wolff, and K.H. Hennermann Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications Ann Hepatol 11 2011 249 259
10. T. Bader Yes! Statins can be given to liver patients J Hepatol 56 2012 305 307